Additional processes contribute to the dermatitis caused by the cpd mutation of Sharpin, including TLR3 signaling (24), NLRP3 inflammasome and IL-1β signaling (25, 26), and IL-4 signaling (27). Here, NLRP3 is linked to skin disorder.